FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385308001> ?p ?o ?g. }

• W4385308001 abstract "Sarcopenia, an age-related decline in muscle mass and physical function, is associated with increased toxicity and worse outcomes in women with breast cancer (BC). Sarcopenia may contribute to toxicity-related early discontinuation of adjuvant endocrine therapy (aET) in women with hormone receptor-positive (HR+) BC but remains poorly characterized.This multicenter, retrospective cohort study included consecutive women with stage 0-II HR+ BC who received breast conserving therapy (lumpectomy and radiation therapy) and aET from 2011 to 2017 with a 5-year follow-up. Skeletal muscle index (SMI, cm2/m2) was analyzed using a deep learning model on routine cross-sectional radiation simulation imaging; sarcopenia was dichotomized according to previously validated reports. The primary endpoint was toxicity-related aET discontinuation; logistic regression analysis evaluated associations between SMI/sarcopenia and aET discontinuation. Cox regression analysis evaluated associations with time to aET toxicity, ipsilateral breast tumor recurrence (IBTR), and disease-free survival (DFS).A total of 305 women (median follow-up, 89 months) were included with a median age of 67 years and early-stage BC (12% stage 0, 65% stage I). A total of 60 (20%) women experienced toxicity-related aET discontinuation. Sarcopenia was associated with toxicity-related early discontinuation of aET (odds ratio, 2.18; P = .036) and shorter time to aET toxicity (hazard ratio [HR], 1.62; P = .031). SMI or sarcopenia were not independently associated with IBTR or DFS; toxicity-related aET discontinuation was associated with worse IBTR (HR, 9.47; P = .002) and worse DFS (HR, 4.53; P = .001).Among women with early-stage HR+ BC who receive adjuvant radiation therapy and hormone therapy, sarcopenia is associated with toxicity-related early discontinuation of aET. Further studies should validate these findings in women who did not receive adjuvant radiation therapy. These high-risk patients may be candidates for aggressive symptom management and/or alternative treatment strategies to improve outcomes." @default.
• W4385308001 created "2023-07-28" @default.
• W4385308001 creator A5000172075 @default.
• W4385308001 creator A5001915853 @default.
• W4385308001 creator A5004621461 @default.
• W4385308001 creator A5010429902 @default.
• W4385308001 creator A5023379460 @default.
• W4385308001 creator A5029206014 @default.
• W4385308001 creator A5032332609 @default.
• W4385308001 creator A5036335426 @default.
• W4385308001 creator A5050620242 @default.
• W4385308001 creator A5052943021 @default.
• W4385308001 creator A5065657208 @default.
• W4385308001 creator A5065695316 @default.
• W4385308001 creator A5066003437 @default.
• W4385308001 date "2023-07-01" @default.
• W4385308001 modified "2023-09-26" @default.
• W4385308001 title "Sarcopenia and toxicity-related discontinuation of endocrine therapy in women with early-stage hormone-receptor-positive breast cancer" @default.
• W4385308001 cites W1970642927 @default.
• W4385308001 cites W1982853521 @default.
• W4385308001 cites W1987753117 @default.
• W4385308001 cites W1996337195 @default.
• W4385308001 cites W2015473392 @default.
• W4385308001 cites W2046529949 @default.
• W4385308001 cites W2055560401 @default.
• W4385308001 cites W2104357394 @default.
• W4385308001 cites W2109997465 @default.
• W4385308001 cites W2110767908 @default.
• W4385308001 cites W2118728607 @default.
• W4385308001 cites W2128585633 @default.
• W4385308001 cites W2139184041 @default.
• W4385308001 cites W2140156103 @default.
• W4385308001 cites W2145166201 @default.
• W4385308001 cites W2146221154 @default.
• W4385308001 cites W2147993322 @default.
• W4385308001 cites W2148003100 @default.
• W4385308001 cites W2150962478 @default.
• W4385308001 cites W2152963742 @default.
• W4385308001 cites W2161977537 @default.
• W4385308001 cites W2275733417 @default.
• W4385308001 cites W2395258407 @default.
• W4385308001 cites W2505846117 @default.
• W4385308001 cites W2584563327 @default.
• W4385308001 cites W2757748705 @default.
• W4385308001 cites W2767600184 @default.
• W4385308001 cites W2796428104 @default.
• W4385308001 cites W2883061070 @default.
• W4385308001 cites W2888188734 @default.
• W4385308001 cites W2897513125 @default.
• W4385308001 cites W2903837191 @default.
• W4385308001 cites W2918922819 @default.
• W4385308001 cites W2970612099 @default.
• W4385308001 cites W2992619229 @default.
• W4385308001 cites W2993667428 @default.
• W4385308001 cites W3112737221 @default.
• W4385308001 cites W3155976338 @default.
• W4385308001 cites W3161826384 @default.
• W4385308001 cites W3165327555 @default.
• W4385308001 cites W3210990061 @default.
• W4385308001 cites W4205771423 @default.
• W4385308001 cites W4206051389 @default.
• W4385308001 cites W4206841660 @default.
• W4385308001 cites W4211144975 @default.
• W4385308001 cites W4223463164 @default.
• W4385308001 cites W4226017051 @default.
• W4385308001 cites W4291019976 @default.
• W4385308001 cites W4296162585 @default.
• W4385308001 cites W4320892490 @default.
• W4385308001 cites W3170426587 @default.
• W4385308001 doi "https://doi.org/10.1016/j.ijrobp.2023.07.018" @default.
• W4385308001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37506979" @default.
• W4385308001 hasPublicationYear "2023" @default.
• W4385308001 type Work @default.
• W4385308001 citedByCount "0" @default.
• W4385308001 crossrefType "journal-article" @default.
• W4385308001 hasAuthorship W4385308001A5000172075 @default.
• W4385308001 hasAuthorship W4385308001A5001915853 @default.
• W4385308001 hasAuthorship W4385308001A5004621461 @default.
• W4385308001 hasAuthorship W4385308001A5010429902 @default.
• W4385308001 hasAuthorship W4385308001A5023379460 @default.
• W4385308001 hasAuthorship W4385308001A5029206014 @default.
• W4385308001 hasAuthorship W4385308001A5032332609 @default.
• W4385308001 hasAuthorship W4385308001A5036335426 @default.
• W4385308001 hasAuthorship W4385308001A5050620242 @default.
• W4385308001 hasAuthorship W4385308001A5052943021 @default.
• W4385308001 hasAuthorship W4385308001A5065657208 @default.
• W4385308001 hasAuthorship W4385308001A5065695316 @default.
• W4385308001 hasAuthorship W4385308001A5066003437 @default.
• W4385308001 hasConcept C121608353 @default.
• W4385308001 hasConcept C126322002 @default.
• W4385308001 hasConcept C143998085 @default.
• W4385308001 hasConcept C167135981 @default.
• W4385308001 hasConcept C207103383 @default.
• W4385308001 hasConcept C2776214593 @default.
• W4385308001 hasConcept C2778715236 @default.
• W4385308001 hasConcept C29730261 @default.
• W4385308001 hasConcept C44249647 @default.
• W4385308001 hasConcept C50382708 @default.
• W4385308001 hasConcept C530470458 @default.
• W4385308001 hasConcept C71924100 @default.

• next